TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis Therapy
Researchers from Hamamatsu University, Department of Internal Medicine provide details of new studies and findings in the area of tuberculosis therapy
December 2nd, 2008
New research, 'Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs,' is the subject of a report. "Tuberculosis (TB) is a worldwide infectious disease. Recently, standard therapy has become very effective for treating patients with TB; however, as a result of this powerful regimen, serious side effects have become an important problem," investigators in Hamamatsu, Japan report. "The aim of this prospective study was to evaluate the usefulness of the drug lymphocyte stimulation test (DLST) to determine anti-TB drugs causing side effects. Four hundred thirty-six patients with TB were admitted to our hospital for treatment...
Source: TB & Outbreaks Week (2008-12-02)
|
